HY-P80229-10uL
|
MedChemexpress LLC
|
Mre11 Antibody
|
|
|
|
HY-P80229-100uL
|
MedChemexpress LLC
|
Mre11 Antibody
|
|
|
|
HY-P80229-50uL
|
MedChemexpress LLC
|
Mre11 Antibody
|
|
|
|
HY-114209-10mg
|
MedChemexpress LLC
|
MRK-740 [CAS 2387510-80-5]
|
|
Cancer-programmed cell death
|
|
HY-114209-100mg
|
MedChemexpress LLC
|
MRK-740 [CAS 2387510-80-5]
|
|
Cancer-programmed cell death
|
|
HY-114209-25mg
|
MedChemexpress LLC
|
MRK-740 [CAS 2387510-80-5]
|
|
Cancer-programmed cell death
|
|
HY-114209-5mg
|
MedChemexpress LLC
|
MRK-740 [CAS 2387510-80-5]
|
|
Cancer-programmed cell death
|
|
HY-114209-50mg
|
MedChemexpress LLC
|
MRK-740 [CAS 2387510-80-5]
|
|
Cancer-programmed cell death
|
|
HY-114209-1mL
|
MedChemexpress LLC
|
MRK-740 [CAS 2387510-80-5] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
HY-153356-10mg
|
MedChemexpress LLC
|
MRT-2359 [CAS 2803881-11-8]
|
|
Cancer-programmed cell death
|
|
HY-153356-100mg
|
MedChemexpress LLC
|
MRT-2359 [CAS 2803881-11-8]
|
|
Cancer-programmed cell death
|
|
HY-153356-5mg
|
MedChemexpress LLC
|
MRT-2359 [CAS 2803881-11-8]
|
|
Cancer-programmed cell death
|
|
HY-153356-50mg
|
MedChemexpress LLC
|
MRT-2359 [CAS 2803881-11-8]
|
|
Cancer-programmed cell death
|
|
HY-136927-10mg
|
MedChemexpress LLC
|
MSA-2 [CAS 129425-81-6]
|
|
COVID-19-immunoregulation
|
|
HY-136927-100mg
|
MedChemexpress LLC
|
MSA-2 [CAS 129425-81-6]
|
|
COVID-19-immunoregulation
|
|
HY-136927-25mg
|
MedChemexpress LLC
|
MSA-2 [CAS 129425-81-6]
|
|
COVID-19-immunoregulation
|
|
HY-136927-5mg
|
MedChemexpress LLC
|
MSA-2 [CAS 129425-81-6]
|
|
COVID-19-immunoregulation
|
|
HY-136927-50mg
|
MedChemexpress LLC
|
MSA-2 [CAS 129425-81-6]
|
|
COVID-19-immunoregulation
|
|
HY-136927-1mL
|
MedChemexpress LLC
|
MSA-2 [CAS 129425-81-6] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-141514-10mg
|
MedChemexpress LLC
|
MSA-2 dimer [CAS 2377881-92-8]
|
|
COVID-19-immunoregulation
|
|
HY-141514-100mg
|
MedChemexpress LLC
|
MSA-2 dimer [CAS 2377881-92-8]
|
|
COVID-19-immunoregulation
|
|
HY-141514-25mg
|
MedChemexpress LLC
|
MSA-2 dimer [CAS 2377881-92-8]
|
|
COVID-19-immunoregulation
|
|
HY-141514-5mg
|
MedChemexpress LLC
|
MSA-2 dimer [CAS 2377881-92-8]
|
|
COVID-19-immunoregulation
|
|
HY-141514-50mg
|
MedChemexpress LLC
|
MSA-2 dimer [CAS 2377881-92-8]
|
|
COVID-19-immunoregulation
|
|
HY-123872-10mg
|
MedChemexpress LLC
|
MSC1094308 [CAS 2219320-08-6]
|
|
|
|